IDDF2021-ABS-0151 A Retrospective Analysis of Paclitaxel (albumin Binding Type) Combined with S-1 Compared with Sox Regimen As First-Line Treatment for Lauren Diffuse Type Advanced Gastric Cancer

Background To investigate the efficacy and safety of Paclitaxel (albumin binding type) combined with S-1 compared with SOX regimen in the treatment of Lauren diffuse-type advanced gastric cancer. The group treated with combined with S-1 the and evaluated efficacy. disease control rate of the and the control group was (12/25). The control rate of the treatment group was higher than the control group, and the difference was statistically significant (P < The main side effects of the two groups were myelo-suppression and gastrointestinal reactions, mostly grade I-II. The of leucopenia, reduction and thrombocytopenia in the the control Other and gallbladder polyps.